BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4371315)

  • 1. Immunotherapy of guinea pig cancer with BCG.
    Zbar B; Rapp HJ
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1532-40. PubMed ID: 4371315
    [No Abstract]   [Full Text] [Related]  

  • 2. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets.
    Zbar B; Ribi E; Meyer T; Azuma I; Rapp HJ
    J Natl Cancer Inst; 1974 May; 52(5):1571-7. PubMed ID: 4364736
    [No Abstract]   [Full Text] [Related]  

  • 4. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
    Yarkoni E; Peters L; Rapp HJ; Hanna MG; Hunter JT
    Infect Immun; 1979 May; 24(2):565-66. PubMed ID: 378859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy with nonviable microbial components.
    Ribi E; Milner KC; Granger DL; Kelly MT; Yamamoto K; Brehmer W; Parker R; Smith RF; Strain SM
    Ann N Y Acad Sci; 1976; 277(00):228-38. PubMed ID: 187099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy of cancer with BCG].
    Yamamura Y; Azuma I
    Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 9. BCG and cancer (first of two parts).
    Bast RC; Zbar B; Borsos T; Rapp HJ
    N Engl J Med; 1974 Jun; 290(25):1413-20. PubMed ID: 4364286
    [No Abstract]   [Full Text] [Related]  

  • 10. Mycobacterial cell wall components in tumor suppression and regression.
    Ribi EE; Meyer TJ; Azuma I; Zbar B
    Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG.
    Harmel RP; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1975 Feb; 54(2):515-7. PubMed ID: 234537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis.
    Zbar B; Tanaka T
    Science; 1971 Apr; 172(3980):271-3. PubMed ID: 4323415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma.
    Meyer TJ; Ribi EE; Azuma I; Zbar B
    J Natl Cancer Inst; 1974 Jan; 52(1):103-11. PubMed ID: 4359409
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy and vaccination against cancer with non-living BCG and cord factor (trehalose-6,6'-dimycolate).
    Bekierkunst A
    Int J Cancer; 1975 Sep; 16(3):442-7. PubMed ID: 170221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against guinea pig hepatomas by pretreatment with subcelluar fractions of Mycobacterium bovis (BCG).
    Minden P; Wainberg M; Weiss DW
    J Natl Cancer Inst; 1974 May; 52(5):1643-5. PubMed ID: 4364739
    [No Abstract]   [Full Text] [Related]  

  • 16. Intratumor chemoimmunotherapy with mitomycin C and components from mycobacteria in regression of line 10 tumors in guinea pigs.
    McLaughlin CA; Cantrell JL; Ribi E; Goldberg EP
    Cancer Res; 1978 May; 38(5):1311-6. PubMed ID: 205361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvants for a tumor-specific vaccine: Bordetella pertussis or mycobacterial cell walls attached to oil droplets.
    Bartlett GL; Zbar B
    J Natl Cancer Inst; 1973 May; 50(5):1385-90. PubMed ID: 4351399
    [No Abstract]   [Full Text] [Related]  

  • 18. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract]   [Full Text] [Related]  

  • 19. An experimental model for immunotherapy of cancer.
    Zbar B; Ribi E; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():3-9. PubMed ID: 4595326
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor regression caused by endotoxins and mycobacterial fractions.
    Ribi EE; Granger DL; Milner KC; Strain SM
    J Natl Cancer Inst; 1975 Nov; 55(5):1253-7. PubMed ID: 173865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.